Sign in
One Year Follow-Up in a Phase ½ Clinical Trial of a Gene Modifier Therapy (OCU400) for the Treatment of Retinitis Pigmentosa
Benjamin Bakall, MD, PhD
Updates from the Field
2024
The Good, the Bad, and the Best of Wnt Signaling
Kimberly A. Drenser, MD
Annual Meeting Talks
2019
Retinitis Pigmentosa
Avris Romario Diparaja Siahaan
Retina Image Bank: Images of the Week
2015
Category: Hereditary Retinal Disease & Genetics